Ampol Limited
CTXAY | OTC
$54.29
+$0.88 (+1.65%)
Nov 2, 2026, 11:19 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 31B | 34.85B | 37.75B | 38.25B | 20.88B | 15.18B |
Cost of Revenue | 28.88B | 32.42B | 34.82B | 35.68B | 19.39B | 14.2B |
Gross Profit | 2.12B | 2.43B | 2.93B | 2.57B | 2.03B | 975.1M |
Operating Income | 261.8M | 454.4M | 1.03B | 859M | 629.7M | -482.2M |
Interest Income | 7.1M | 6.7M | 11.3M | 5.1M | 400K | 600K |
Pretax Income | 178.2M | 228.6M | 751.6M | 936.5M | 734.4M | -725.6M |
Net Income | 82.4M | 122.5M | 549.1M | 795.9M | 560M | -484.9M |
Selling & General & Admin | 1.86B | 876.4M | 1.93B | 1.75B | 1.36B | 1.47B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -6.2M | 1.1B | -35.2M | -164.2M | -189.1M | -176.2M |
Operating Expenses | 1.86B | 1.97B | 1.89B | 1.58B | 1.17B | 1.29B |
Interest Expense | 302.5M | 343.1M | 282.6M | 200.8M | 103.5M | 100.3M |
Selling & Marketing Expenses | n/a | n/a | 1.66B | 1.48B | 1.15B | 1.13B |
Cost & Expenses | 30.73B | 34.39B | 36.72B | 37.42B | 20.05B | 15.66B |
Income Tax Expense | 41.6M | 53M | 151.5M | 157.9M | 175.8M | -245.8M |
Shares Outstanding (Basic) | 238.3M | 238.3M | 238.3M | 238.3M | 239.1M | 249.7M |
Shares Outstanding (Diluted) | 239M | 239.3M | 238.8M | 239.5M | 239.8M | 249.7M |
EPS (Basic) | 0.35 | 0.51 | 2.30 | 3.34 | 2.34 | -1.94 |
EPS (Diluted) | 0.34 | 0.51 | 2.30 | 3.32 | 2.34 | -1.94 |
EBITDA | 753.2M | 973.8M | 1.5B | 1.49B | 1.19B | -213.8M |
EBIT | 261.8M | 489.6M | 1.04B | 1.05B | 826.6M | -636M |
Depreciation & Amortization | 491.4M | 484.2M | 458.9M | 438.4M | 364.2M | 422.2M |
Add to Watchlist
Select watchlists to add or remove CTXAY